Acid sphingomyelinase plays important roles in ceramide homeostasis, which has been proposed to be linked to insulin resistance. To test this association in vivo, acid sphingomyelinase deletion (asm ؊/؊ ) was transferred to mice lacking the low density lipoprotein receptor (ldlr ؊/؊ ), and then offsprings were placed on control or modified (enriched in saturated fat and cholesterol) diets for 10 weeks. The modified diet caused hypercholesterolemia in all genotypes; however, in contrast to asm ؉/؉ /ldlr ؊/؊ , the acid sphingomyelinase-deficient littermates did not display hepatic triacylglyceride accumulation, although sphingomyelin and other sphingolipids were substantially elevated, and the liver was enlarged. asm ؊/؊ /ldlr ؊/؊ mice on a modified diet did not accumulate body fat and were protected against diet-induced hyperglycemia and insulin resistance. Experiments with hepatocytes revealed that acid sphingomyelinase regulates the partitioning of the major fatty acid in the modified diet, palmitate, into two competitive and inversely related pools, triacylglycerides and sphingolipids, apparently via modulation of serine palmitoyltransferase, a rate-limiting enzyme in de novo sphingolipid synthesis. These studies provide evidence that acid sphingomyelinase activity plays an essential role in the regulation of glucose metabolism by regulating the hepatic accumulation of triacylglycerides and sphingolipids during consumption of a diet rich in saturated fats.
Obesity is the major risk factor associated with the development of glucose intolerance and type 2 diabetes. In obesity, large amounts of triacylglycerides (TAG) 3 accumulate in liver, a so-called "lean tissue," and hepatic TAG accumulation is a better predictor for development of type 2 diabetes than body weight or body mass index (1) . Liver plays a central role in the metabolism and storage of dietary fat (2) . Depending on the hormonal and nutritional status of the organism, hepatocytes ␤-oxidize fatty acids derived from adipose tissue, chylomicron remnants, and other lipoprotein sources or reutilize them for the biosynthesis of TAG and other lipids. However, when dietary fat is in excess, TAG-rich droplets accumulate in the cytosol, resulting in "fatty liver" and lipotoxicity (3, 4) . Another lipid that accumulates is ceramide (5) , which has been proposed to contribute to insulin resistance and lipotoxicity (6 -8) because of suppression of IRS-1 phosphorylation in hepatocytes (9) and inhibition of Rac activation, Glut-4 translocation, and Akt-1 phosphorylation in muscle cells (10, 11) . Ceramide is generated via de novo biosynthesis and turnover of complex sphingolipids such as sphingomyelin (SM). The ratelimiting step in the de novo pathway is catalyzed by serine palmitoyltransferase (SPT), which exhibits a high degree of specificity for the CoA-thioester of palmitic acid, the major saturated fatty acid found in the Western diet. Moreover, ceramide biosynthesis de novo has been shown to be influenced by the supply of palmitic acid in hepatocytes (12) , muscle (8, 13, 14) , and heart (15) . Acid sphingomyelinase (ASMase), in turn, generates ceramide by hydrolysis of SM from the recycling/ endocytic pathway. ASMase might play a role in obesity because it is overexpressed in adipose tissue of ob/ob mice (16) , and it appears to be involved in the pathogenesis of atherosclerosis (17), a disease which, similar to diabetes, is linked to obesity and to the consumption of diets rich in saturated fats. In contrast, patients with deficient ASMase activity (NiemannPick patients) maintain very low body weight (18) .
In this study we investigate the link between high fat diets, ceramide, and insulin resistance in vivo, and we provide evidence that ASMase plays a critical role in regulation of insulin sensitivity and blood glucose by modulating the partitioning of palmitic acid in sphingolipid and TAG pools in the liver.
EXPERIMENTAL PROCEDURES
Animals and Diets-A colony of ASMase-deficient mice (19) was maintained in Division of Laboratory Animal Resources of the University of Kentucky College of Medicine. ASMase deletion was bred to ldlr Ϫ/Ϫ background by cross-breeding asm ϩ/Ϫ and ldlr Ϫ/Ϫ (Ldlr tm1Her (C57Bl6), The Jackson Laboratory, Bar Harbor, ME). asm ϩ/Ϫ /ldlr Ϫ/Ϫ animals were maintained as a breeding heterozygous colony and used as a parental strain to generate asm Ϫ/Ϫ /ldlr Ϫ/Ϫ and asm ϩ/ϩ /ldlr Ϫ/Ϫ for the experiments. Eight-to-9-week-old male and female litter-matched animals were randomly placed either on a modified diet (TD.88137, adjusted calories diet, 42% from fat) (Harlan-Teklad, Indianapolis, IN) or continued on standard chow diet (2918, Teklad Global 18% protein rodent diet) (Harlan-Teklad) and fed ad libitum for 10 weeks. Two to four animals per cage were housed in micro-isolation in a 12-h light/dark cycle at the University of Kentucky Animal Care Facility according to the criteria outlined in the University of Kentucky Animal Resources and Procedures Handbook. Body weight was monitored twice a week. Randomly chosen mice from each group were housed individually in metabolic cages for 7 days in the second half of the 10-week period to measure food and water intake, feces, and urine. At the end of the diet blood was withdrawn by heart puncture, and various organs were collected, flash-frozen in liquid nitrogen, and stored at Ϫ80°C until further processing.
Histological Studies in Fat and Liver Tissues-Adipose tissue samples were fixed in 3.7% paraformaldehyde in phosphatebuffered saline and processed for paraffin embedding, slicing, and hematoxylin and eosin staining. Flash-frozen sections were used for hematoxylin and eosin and Oil Red-O staining of liver.
Lipid Analysis-Total lipids were extracted as described previously (20) . The lipid extracts were analyzed by TLC on silica gel 60 plates using chloroform:methanol:triethylamine:2-propanol: potassium chloride (0.25%) (30:9:18:25:6, by volume) as the developing solvent. The regions migrating with a standard ceramide (bovine brain) (Avanti Polar Lipids, Alabaster, AL) were scraped off plates, and the lipids were eluted. After the addition of an internal standard, N-hexanoyl-C 20 -sphinganine (Avanti Polar Lipids, Alabaster, AL), the ceramide mass was quantified by HPLC (21) . Free sphingoid bases were quantified by HPLC using C 20 sphinganine (Matreya Inc., Pleasant Gap, PA) as an internal standard (21) . For quantification of individual phospholipid classes, the regions corresponding to standard SM, PC, PS, and PE were sprayed with 50% sulfuric acid and incubated at 190 -200°C for 2-2.5 h. Inorganic phosphorus was measured according to Kahovkova and Odavic (22) .
Radiolabeled triacylglycerols, ceramide, and SM was quantified after lipid extraction in the presence of the respective carrier and separation by TLC using the following mobile phases: chloroform:acetic acid (94:6, by volume) for TAG; diethyl ether: methanol (99:1, by volume) for ceramide; and chloroform: SPT Activity Assay-SPT activity was measured in microsomes prepared from 30% liver homogenates. After removal by centrifugation of the debris at 500 ϫ g, and the heavy membrane fraction at 20,000 ϫ g, microsomal membranes were pelleted at 105,000 ϫ g for 1 h, resuspended in 100 mM Tris buffer (pH 7.4), and frozen for future use. The SPT activity was assayed using 3 H-labeled L-serine and palmitoyl-CoA as exogenous substrates according to Dickson et al. (23) . Glucose and Insulin Tolerance Tests-Blood glucose was measured 1 week prior to the end of the diet. Mice were fasted overnight (14 -16 h); blood was collected from the tail, and glucose was measured using Accu-Chek active glucometer (Roche Diagnostics). The concentrations of glucose in the fed C]mannitol (PerkinElmer Life Sciences) was added to both muscles for additional 10 min. The muscles were washed extensively, digested in 1 N NaOH, and heated for 10 min at 80°C. The glucose uptake was then quantified by scintillation counting.
Statistical Analysis-Two-way ANOVA with subsequent Bonferroni test was used to determine the significance of changes in multiple comparisons. When the interaction effect of genotype and diet was statistically highly significant, the significance of the diet or genotype alone was confirmed by one-way comparisons as indicated in the legends. Throughout the figures, an asterisk symbolizes the significance of the main effect, and a number sign symbolizes the significance of the interaction effect.
RESULTS

Generation of Mice Deficient in ASMase (asm
mice are responsive to diets rich in saturated fats and develop moderate to severe obesity and metabolic syndrome when fed a diet rich in saturated fats (24 / ldlr Ϫ/Ϫ and asm ϩ/ϩ /ldlr Ϫ/Ϫ animals were placed either on a diet enriched with saturated fats and cholesterol or a standard calorie-adjusted diet for 10 weeks. Palmitic acid was the major saturated fat in the modified diet (Table 1) . ASMase deficiency had no effect on food and water consumption, as well as urine volume and feces amount ( Table  2) . Some diet-related differences were observed, and mice on a modified diet ate significantly more and had a substantial increase in urine volume and a decrease in feces amount as compared with those on normal diet. Furthermore, VLDL and LDL cholesterol (Fig. 1A) and total serum cholesterol (Fig. 1, B and C) were similarly elevated by the modified diet in both genotypes. asm 
/ldlr
Ϫ/Ϫ mice accumulated a substantial amount of body fat. The weight of epididymal fat and retroperitoneal fat pads, which represent subcutaneous and visceral fat respectively, increased by 1.5-2-fold (Fig. 2, A and B) . In contrast, weight of adipose tissue of asm Ϫ/Ϫ /ldlr Ϫ/Ϫ animals on a standard diet was significantly lower than that of asm ϩ/ϩ /ldlr Ϫ/Ϫ mice and did not increase as a result of the modified diet (Fig. 2,  A and B) . Histological analyses confirmed the lack of adipocyte fat accumulation in asm Ϫ/Ϫ /ldlr Ϫ/Ϫ mice (Fig. 2C) . It should be noted that these data are for male mice only and the differences *** *** *** observed in females were even greater; however, the data from females were not included in the analyses because the estrus cycle of each individual mouse was not taken into account.
Genotype and diet both significantly affected liver size (not shown) and weight (Fig. 3A) . Consistent with the hepatomegaly observed in Niemann-Pick patients, ASMase deficiency alone led to hepatic enlargement. In turn, asm ϩ/ϩ /ldlr Ϫ/Ϫ mice on a modified diet also had enlarged liver as compared with those on a standard diet, indicative of fatty liver development. However, the increases in liver weight observed in asm Ϫ/Ϫ /ldlr Ϫ/Ϫ animals on a modified diet were much more substantial (Fig. 3A) . Two-way ANOVA analyses showed a diet and genotype interaction of p Ͻ 0.001.
The effects of modified diet on the liver were further studied by histological analyses using hematoxylin and eosin (Fig. 3B) and Oil red O stains (Fig. 3C) , as well as by direct measurements of TAG concentration (Fig. 3D) . All three approaches confirmed the accumulation of TAG in asm ϩ/ϩ /ldlr Ϫ/Ϫ but not in asm Ϫ/Ϫ /ldlr Ϫ/Ϫ mice on a modified diet, thus eliminating the possibility of lipodystrophy. However, the livers of asm Ϫ/Ϫ / ldlr Ϫ/Ϫ animals exhibited large pale-blue/pink areas similar to ones described in patients with ASMase deficiency and attributed to the accumulation of SM and some glycerophospholipids. Notably, the number and the size of these areas were significantly increased by the modified diet (Fig. 3B) .
The body weight for each group was similar at the beginning of the diet (Table 3) . Mice on the modified diet gain more weight than those on standard diet. Notably, during the first 5 weeks there were no significant genotype-related differences; after that, however, the mice on a modified diet continue to gain weight whereas the weight of the asm Ϫ/Ϫ /ldlr Ϫ/Ϫ mice leveled off.
Accumulation of Phospholipids and Sphingolipids in the Livers of asm
Ϫ/Ϫ
/ldlr
Ϫ/Ϫ Mice on High Fat Diet-In contrast to changes in TAG levels, liver content of the main phospholipids, phosphatidylserine (PS), phosphatidylethanolamine (PE), and phosphatidylcholine (PC), was significantly elevated in asm Ϫ/Ϫ /ldlr Ϫ/Ϫ but not in asm ϩ/ϩ /ldlr Ϫ/Ϫ mice on a modified diet (Fig. 4, B-D) . The SM content elevated in both genotypes as a result of the diet; however, the increase was severalfold higher in asm Ϫ/Ϫ /ldlr Ϫ/Ϫ mice than in asm ϩ/ϩ /ldlr Ϫ/Ϫ mice (Fig. 4A ). Consequently, the SM level in these mice surpassed that of PC, the most abundant phospholipid in normal cells.
The hepatic concentration of both free (unesterified) and esterified cholesterol increased as a result of the high fat diet in all mice (Fig. 4E) , apparently reflecting the elevated dietary cholesterol content. ASMase-deficient mice appeared to have elevated free cholesterol as compared with the respective wild type controls, which was likely because of the inhibitory effect that SM accumulation had on cholesterol esterification (25) .
Stimulation of de Novo Sphingolipid Synthesis by the Modified Diet-Next we sought to determine why ASMase deficiency leads to accumulation of SM rather than TAG in livers of mice on a modified diet. In asm ϩ/ϩ /ldlr Ϫ/Ϫ mice, modified diet had no effect on the activity of ASMase, and thus the direct role of this enzyme seemed unlikely (data not shown). SPT is the enzyme catalyzing the initial rate-limiting step of the de novo synthesis of all complex sphingolipids, including SM. Modified diet led to a substantial increase in the in vitro measured SPT activity in both asm ϩ/ϩ /ldlr Ϫ/Ϫ and asm 5A ). This correlated with increases in the abundance of SPT1 protein (Fig. 5, B and C) . The lack of ASMase did not affect these changes. The liver levels of key intermediates in the de novo synthesis of SM, namely sphinganine, dihydroceramide, and ceramide, increased in both asm ϩ/ϩ /ldlr Ϫ/Ϫ and asm Ϫ/Ϫ / ldlr Ϫ/Ϫ mice fed the modified diet (Fig. 5, D-F) , consistent with the increase in SPT activities. However, the accumulation of these intermediates was much more substantial in asm Ϫ/Ϫ / ldlr Ϫ/Ϫ animals as compared with asm ϩ/ϩ /ldlr Ϫ/Ϫ mice. The diet-induced increase in sphinganine concentration was around 4 pmol/mg⅐protein in asm ϩ/ϩ /ldlr Ϫ/Ϫ mice and around 100 pmol/mg⅐protein in asm Ϫ/Ϫ /ldlr Ϫ/Ϫ animals. For dihydroceramide, these increases were 70 and 340 pmol/mg⅐protein, and for ceramide increases were 0.8 and 5.8 nmol/mg⅐protein, respectively. In contrast, the levels of free sphingosine, which is generated only during ceramide hydrolysis but not synthesis, were similar in asm Ϫ/Ϫ /ldlr Ϫ/Ϫ animals on standard and modified diet (228 Ϯ 15.4 pmol/mg⅐protein and 227.5 Ϯ 21.3 pmol/ mg⅐protein, respectively). The above observations thus agree with previous reports that a diet enriched in saturated fats has a potent stimulatory effect on the rate of sphingolipid synthesis, but the observations also suggest that the magnitude of the effect depends upon hepatic ASMase activity.
ASMase Activity Regulates the Utilization of Exogenous Palmitic Acid for TAG and de Novo Sphingolipid Synthesis-The
link between sphingolipid and TAG synthesis was investigated in HepG2 cells supplemented with palmitic acid at low (0.1 mM) or high (1.0 mM) concentrations. Palmitic acid is a common precursor for both TAG and de novo sphingolipid synthesis. It is also the main saturated fat in the diets commonly consumed in the Western world and has been implicated in the development of insulin resistance and lipotoxicity (26) . In agreement with the in vivo observations reported above, incubation with high concentrations of palmitic acid (Fig. 6A) led to substantial increases in cellular TAG mass; however, these increases were attenuated by desipramine, an inhibitor, which abolished ASMase activity by more than 90% and had no apparent toxicity.
The rate of 3 H-labeled palmitic acid incorporation into TAG (Fig. 6B), ceramide (Fig. 6C) , and, to a lesser extent, SM (data not shown and Fig. 7B ) was also higher when the palmitate was present at high concentrations. These results provide direct evidence that increased supply of palmitic acid stimulates both the synthesis of TAG and sphingolipids. However, inhibition of hepatic ASMase activity reduced the incorporation of radiolabeled palmitate into TAG by 40% (Fig. 6B) , while further increasing that in ceramide (Fig. 6, C and D) and SM (data not shown and see Fig. 7B ). Desipramine-induced increases were also observed in palmitate incorporation into some glycerophospholipids, namely phosphatidylserine and phosphatidylethanolamine (data not shown). The effects of desipramine on the de novo synthesis of sphingolipids were further confirmed when [ 3 H]serine was used as a precursor instead of palmitate (data not shown). Treatment with myriocin ( Fig. 7) and fumonisin B 1 (data not shown), which are specific inhibitors of SPT and dihydroceramide synthase, respectively, attenuated the desipramine effects on ceramide (Fig. 7A) and SM (Fig. 7B) labeling. These observations further supported the role of ASMase as a negative regulator of the rate of sphingolipid synthesis. The most interesting finding, however, was that the myriocin treatment also had an effect on TAG synthesis, and it blocked the desipramine-induced decrease in palmitate incorporation into TAG (Fig. 7C) . Evidently, not only the rates of sphingolipid and TAG synthesis are inversely correlated, but also the decreased flux of palmitate toward TAG synthesis is caused by its increased utilization for sphingolipid synthesis.
Glucose Regulation and Insulin Sensitivity in asm
Ϫ/Ϫ Mice on High Fat Diet-Importantly, the lack of TAG accumulation in asm Ϫ/Ϫ /ldlr Ϫ/Ϫ mice on a modified diet is paralleled by normal blood glucose regulation (Fig. 8) . As can be seen in Fig. 8A , the blood glucose levels of both asm ϩ/ϩ /ldlr Ϫ/Ϫ and asm Ϫ/Ϫ /ldlr Ϫ/Ϫ on a standard diet are higher in fed than in the fasted state. Consistent with the development of hyperglycemia, asm ϩ/ϩ /ldlr Ϫ/Ϫ mice on a modified diet exhibit similar glucose concentrations in the fasted and fed state (Fig. 8A) . In contrast, asm Ϫ/Ϫ /ldlr Ϫ/Ϫ animals showed striking differences in blood glucose concentrations similar to those observed in animals on a standard diet. The ability of asm Ϫ/Ϫ /ldlr Ϫ/Ϫ mice on a modified diet to clear glucose faster than asm ϩ/ϩ /ldlr Ϫ/Ϫ mice is also evident by the enhanced clearance of intraperitoneally administered D-glucose (Fig. 8B) . Finally, insulin tolerance tests administered in vitro in isolated muscle (Fig. 8C ) and in vivo (Fig. 8D ) provide direct evidence that asm Ϫ/Ϫ /ldlr Ϫ/Ϫ animals on a high fat diet are insulin-responsive and confirm further that the ASMase-deficient animals are protected against diet-induced hyperglycemia and insulin resistance.
DISCUSSION
Increased consumption of food rich in saturated fats and cholesterol is a common trend in Western society. It leads to obesity that increases the risk of cardiovascular diseases and type 2 diabetes (3, 4, 27) . Mice lacking the LDL receptor respond to such diets similar to humans; they develop metabolic syndrome (24) , hypercholesterolemia, and atherosclerosis (28). Here we find that when placed on an experimental diet enriched in saturated fats, ldlr Ϫ/Ϫ mice lacking ASMase exhibit normal regulation of blood glucose and normal insulin response, despite the same daily food and water uptake as wild type littermates. In contrast, the diet-induced hypercholesterolemia is not affected by the lack of ASMase.
The amelioration of hyperglycemia and insulin resistance is accompanied by severe inhibition of dietinduced TAG accumulation in liver and adipose tissue. Liver plays a central role in the metabolism and storage of dietary fat and through the VLDL pathway is a major source of fat for other tissues. TAG synthesis is catalyzed by diacylglycerol (DAG) acyltransferase (DGAT), which adds a fatty acid from acyl-CoA to DAG to produce TAG. There are two genetically distinct forms of DGAT, DGAT1 and DGAT2, which play different roles in TAG synthesis, despite similar biochemical characteristics and substrate specificity. Increasing evidence had suggested that the two enzymes are part of a mechanism that coordinates the regulation of TAG and glycerophospholipid synthesis in an apparently competitive manner. Deletion of DGAT1 has only a minor effect on TAG synthesis. Its overexpression is sufficient to elevate synthesis of TAG however; surprisingly, it also reduces that of glycerophospholipids, suggesting that the overexpressed enzyme uses a pool of DAG initially designed for phospholipid synthesis (29) . In contrast, overexpression of DGAT2 has a much greater effect on TAG accumulation than DGAT1, and its silencing inhibits hepatic TAG synthesis (30) . Notably, suppression of DGAT2, but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance (31) . Thus, the two DGAT forms seems to use two metabolically distinct and competitive pools of DAG that are specifically designated for TAG or phospholipid syntheses (29) .
The experiments shown here imply that similar metabolic interactions exist between sphingolipid and TAG synthesis. It is noteworthy that the PC:ceramide phosphorylcholine transferase reaction, which catalyzes SM synthesis, generates one molecule of DAG for each molecule of SM that is synthesized (Fig. 9) . It is possible that extensive stimulation of SM synthesis, as observed in ASMase null mice on saturated fat-enriched diet, might disrupt the DAG pools available for TAG synthesis. This is further supported by the spatial separation of the synthesis of SM that occurs in cisGolgi (32) and by the parallel increase in the levels of glycerophospholipids observed in asm Ϫ/Ϫ /ldlr Ϫ/Ϫ mice fed a high fat diet and in hepatocytes with inhibited ASMase activity.
Several studies have shown that increased supply of palmitic acid elevates de novo synthesis of sphingolipids (12) , including SM, in isolated rat hepatocytes and C 2 C 12 myotubes (5). This study finds similar elevation in de novo synthesis of sphingolipids in animals fed a palmitic acid-rich diet, which parallels the increases in TAG synthesis. Together, these studies provide clear evidence that dietary palmitate partitions between TAG and sphingolipid pools (Fig. 9) . However, our study also finds that the palmitate flux through ceramide and TAG synthetic pathways is regulated in a competitive fashion.
Palmitate-induced ceramide accumulation in muscle has been shown to inhibit insulin-induced translocation of Glut-4 to the plasma membrane and seems to be required for the onset of hyperglycemia (33) . At this point, it is not known whether ASMase deficiency had an effect on ceramide synthesis in muscle, comparable with that observed in liver. It seems, however, that diet-induced accumulation of ceramide may not be sufficient to offset glucose regulation because, at least in liver, it correlated with the onset of hyperglycemia only when accompanied by an accumulation of TAG. This might reflect the complexity of hepatic insulin response, which regulates the rate of glycogenolysis and gluconeogenesis, instead of the active glucose uptake. It seems that the capacity of liver to handle excess dietary fat and to accumulate TAG has a prominent role in the regulation of overall glucose homeostasis.
Cellular ASMase activity emerges as a critical factor that determines the pathway for utilization of exogenous palmitate because of the following. (i) ASMase deficiency in mice augments dietary-induced increases in dihydroceramide and sphinganine, which are intermediates only in the de novo pathway; concomitantly, it abolishes TAG accumulation. (ii) Similarly, inhibition of ASMase activity in HepG2 cells stimulates de novo FIGURE 9 . Schematic representation of metabolic links between sphingolipids, glycerolipids, and TAG in liver. Pathways for the de novo SM synthesis from palmitate (solid green background), turnover of SM to ceramide and consequently to sphingosine and sphingosine-phosphate (striped green background), as well as synthesis of phospholipids and TAG from common precursor, phosphatidic acid (pink background), are shown. The experiments in this study suggest that in liver palmitic acid may partition between sphingolipid and TAG pools in a competitive manner that is influenced by the rate of lysosomal turnover of SM.
sphingolipid synthesis while inhibiting palmitate-induced TAG synthesis and accumulation. (iii) Pharmacological inhibitors of the de novo sphingolipid synthesis ameliorate the effects of ASMase deficiency on both sphingolipid and TAG synthesis.
The mechanism by which ASMase deficiency promotes increased de novo synthesis of sphingolipids is unclear. One possibility is that ASMase is part of a negative feedback mechanism for regulation of sphingolipid synthesis depending on the exogenous supply of SM. Indeed, a recent study has suggested that sphingosine 1-phosphate, a metabolite of the terminal turnover of sphingolipids might influence the rate of the de novo synthesis (34) . Alternatively, ASMase deficiency has been implicated in deregulation of lipid trafficking (35) and transcriptional regulation of lipid metabolism, including the activity of sterol regulatory element-binding protein (36) that could have profound effects on coordinated regulation of sphingolipid and TAG synthesis. Nevertheless, these observations provide a novel insight into the mechanisms of diet-related hepatic steatosis and its role in insulin resistance, opening new possibilities for treatment of obesity-related pathologies.
